Cathepsin B fraction active at physiological pH of 7.5 is of prognostic significance in squamous cell carcinoma of human lung

British Journal of Cancer

Volumn 75, Issue 8, 1997, Pages 1137-1143

  Werle, B ^a   Julke B ^a   Lah, T ^b   Spiess, E ^c   Ebert, W ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b JO EF STEFAN INSTITUTE   (Slovenia)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

CA 074; Cathepsin B; Lung cancer

Indexed keywords

CATHEPSIN B; ENZYME INHIBITOR; N [N (3 CARBOXYOXIRANE 2 CARBONYL)LEUCYL]AGMATINE;

ADOLESCENT; AGED; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME SPECIFICITY; ENZYME STABILITY; ENZYME SUBSTRATE; HUMAN; HUMAN TISSUE; LUNG CARCINOMA; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; PH; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; SURGICAL MORTALITY;

EID: 0030996271     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.196     Document Type: Article

References (42)

1. Abel U, Berger J and Wiebelt H (1984) Critlevel. An exploratory procedure for the evaluation of quantitative prognostic factors. Methods Inf Med 23: 154-156
2. Barrett AJ and Kirschke H (1981) Cathepsin B, Cathepsin H, and Cathepsin L. In Methods in Enzymology, Lorand L (ed), Vol. 80, pp. 535-561. Academic Press: New York
3. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254
4. Buck MR, Karustis DG, Day NA, Honn KV and Sloane BF (1992) Degradation of extracellular-matrix proteins by human Cathepsin B from normal and tumour tissues. Biochem J 282: 273-278
5. Buttle DJ, Murata M, Knight CG and Barrett AJ (1992) CA074 methyl ester: A proinhibitor for intracellular cathepsin B. Arch Biochem Biophys 299: 377-380
6. Campo E, Munoz J, Miquel R, Palacin A, Cardesa A, Sloane BF and Emmert-Buck MR (1994) Cathepsin B expression in colorectal carcinomas correlates with tumor progression and shortened patient survival. Am J Pathol 145: 301-309
7. Deval C, Bechet D, Obled A and Ferrara M (1990) Purification and properties of different isoforms of bovine cathepsin B. Biochem Cell Biol 68: 822-826
8. Dufek V, Matous B and Krai V (1984) Serum alkaline-stable acid thiol proteinase - a possible marker for primary liver carcinoma. Neoplasma 31: 99-107
9. Ebert W, Knoch H, Werle B, Trefz G, Muley TH and Spiess E (1994) Prognostic value of increased lung tumor tissue cathepsin B. Anticancer Res 14: 895-900
10. Hasnain S, Hirama T, Tam A and Mort JS (1992) Characterization of recombinant rat cathepsin B and nonglycosylated mutants expressed in yeast. J Biol Chem 267: 4713-4721
11. Hermanek P and Sobin L (1987) TNM Classification of Malignant Tumours. International Union against Cancer (UICC), 4th edn. Springer: Berlin
12. Inoue T, Ishida T, Sugio K and Sugimachi K (1994) Cathepsin B expression and laminin degradation as factors influencing prognosis of surgically treated patients with lung adenocarcinoma. Cancer Res 54: 6133-6136
13. Kaplan EL and Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481
14. Kirschke H, Barrett AJ and Rawlings ND (1995) Proteinases 1: lysosomal cysteine proteinases. In Protein Profile, Sheterline P (ed), Vol. 2, pp. 1587-1643. Academic Press: London.
15. Knoch H, Werle B, Ebert W and Spiess E (1994) Imbalance between cathepsin B and cysteine proteinase inhibitors is of prognostic significance in human lung cancer. Int J Oncol 5: 77-85
16. Koga H, Yamada H, Nishimura Y, Kato K and Imoto T (1991) Multiple proteolytic action of rat liver cathepsin B: specificities and pH-dependence of the endo and exopeptidase activities. J Biochem (Tokyo) 110: 179-188
17. Krepela E, Kasafirek E, Novak K and Viklicky J (1990) Increased cathepsin B activity in human lung tumors. Neoplasma 37: 61-70
18. Krepela E, Prochazka J, Mynarikova H, Karova B, Polak J, Cermak J and Roubkova H (1995) Multiple forms of cathepsin B in human lung cancer, Int J Cancer 61: 44-53
19. Lah TT, Buck M, Honn KV, Crissmann JD, Rao NC, Liotta LA and Sloane BF (1989) Degradation of laminin by human tumor cathepsin B. Clin Expl Metastasis 7: 461-168
20. Ledakis P, Tester W, Rosenberg N, Cohen M, Daskal I and Lah TT (1996) Cathepsins D, B and L in human lung carcinoma. Clin Cancer Res 2: 561-568
21. Machleidt-Assflag I, Jochum M, Klaubert W, Inthorn D and Machleidt W (1988) Enzymatically active cathepsin B dissociating from its inhibitor complexes is elevated in blood plasma of patients with septic shock and some malignant tumors. Biol Chem Hoppe-Seyler 396 (suppl.): 263-269
22. Moin K, Day NA, Sameni M, Hasnain S, Hirama T and Sloane BF (1992) Human tumour cathepsin B. Comparison with normal liver cathepsin B. Biochem J 285: 427-434
23. Mort JS, Recklies AD and Poole AR (1980) Characterization of a thiol proteinase secreted by malignant human breast tumours. Biochim Biophys Acta 614: 134-143
24. Pagano M, Dalet-Fumeron V and Engler R (1989) The glycosylation state of the precursors of the cathepsin B-like proteinase from human malignant ascitic fluid: possible implication in the secretory pathway of these proenzymes. Cancer Lett 45: 13-19
25. Pedersen H, Brünner N, Francis D, Osterlind K, Ronne E, Hansen HH, Dano K and Grondahl-Hansen J (1994a) Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue. Cancer Res 54: 4671-4675
26. Pedersen H, Grondahl-Hansen J, Francis D, Osterlind K, Hansen HH, Dano K and Brünner N (1994b) Urokinase and plasminogen activator inhibitor type 1 in pulmonary adenocarcinoma. Cancer Res 54: 120-123
27. Pietras RJ and Roberts JA (1981) Cathepsin B-like enzymes. Subcellular distribution and properties in neoplastic and control cells from human ectocervix. J Biol Chem 256: 8536-8544
28. Pietras RJ, Szego CM, Mangan CE, Seeler BJ and Burtnett MM (1979) Elevated serum cathepsin B1-like activity in women with neoplastic disease. Gynecol Oncol 7: 1-17
29. Polgar L and Csoma C (1987) Dissociation of ionizing groups in the binding cleft inversely controls the endo- and exopeptidase activities of cathepsin B. J Biol Chem 262: 14448-14453
30. Ryan RE, Sloane BF, Sameni M and Wood PL (1995) Microglial cathepsin B: an immunological examination of cellular and secreted species. J Neurochem 65: 1035-1045
31. Sedo A, Krepela E and Kasafirek E (1991) Dipeptidylpeptidase IV. prolyl endopeptidase and cathepsin B activities in primary human lung tumors and lung parenchyma. J Cancer Res Clin Oncol 117: 249-253
32. Sheahan K, Shuja S and Murnane MJ (1989) Cysteine protease activities and tumor development in human colorectal carcinoma. Cancer Res 49: 3809-3814
33. Sloane BF, Moin K, Sameni M, Tait LR, Rozhin J and Ziegler G (1994) Membrane association of cathepsin B can be induced by transfection of human breast epithelial cells with c-Ha-ras oncogene. J Cell Science 107: 373-384
34. Smith RE, Rasnick D, Burdick CO, Cho K, Rose JC and Vahratian A (1988) Visualization of time-dependent inactivation of human tumor cathepsin B isozymes by a peptidyl fluoromethyl ketone using a fluorescent print technique. Anticancer Res 8: 525-530
35. 2-macroglobulin and other serum proteins. Biochem J 131: 823-831
36. Sukoh N, Abe S, Ogura S, Isobe H, Takekawa H, Inoue K and Kawakami Y (1994a) Immunohistochemical study of cathepsin B. Prognostic significance in human lung cancer. Cancer 74: 46-51
37. Sukoh N, Abe S, Nakajima I, Ogura S, Isobe H, Inoue K and Kawakami Y (1994b) Immunohistochemical distributions of cathepsin B and basement membrane antigens in human lung adenocarcinoma: association with invasion and metastasis. Virchows Arch 424: 33-38
38. Turk B, Dolenc I, Zerovnik E, Turk D, Gubensek F and Turk V (1994) Human cathepsin B is a metastable enzyme stabilized by specific ionic interactions associated with the active site. Biochemistry 33: 14800-14806
39. Werle B, Ebert W, Klein W and Spiess E (1995) Assessment of cathepsin L activity by use of the inhibitor CA-074 compared to cathepsin B activity in human lung tumor tissue. Biol Chem Hoppe-Seyler 376: 157-164
40. Werle B, Ebert W, Klein W and Spiess E (1996) Charge polymorphism in human lung cell pro-cathepsin B. Anticancer Res 16: 49-54
41. Willenbrock F and Brocklehurst K (1985) A general framework of cysteine-proteinase mechanism deduced from studies on enzymes with structurally different analogous catalytic-site residues Asp-158 and - 161 (papain and actinidin), Gly-196 (cathepsin B) and Asn-165 (cathepsin H). Biochem J 227: 521-528
42. World Health Organization (1981) Histological Classification of Lung Tumors. WHO: Geneva